William Blair Issues Pessimistic Estimate for CRSP Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at William Blair reduced their Q1 2025 EPS estimates for CRISPR Therapeutics in a research note issued to investors on Tuesday, February 11th. William Blair analyst S. Corwin now anticipates that the company will post earnings of ($1.05) per share for the quarter, down from their […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at William Blair reduced their Q1 2025 EPS estimates for CRISPR Therapeutics in a research note issued to investors on Tuesday, February 11th. William Blair analyst S. Corwin now anticipates that the company will post earnings of ($1.05) per share for the quarter, down from their […]
